These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 8962206)

  • 21. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
    Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
    J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytotoxic T-cell elimination during anti-CD4-induced rat liver acceptance and rapid replacement of functional graft antigen-presenting cells.
    Usui K; Yamaguchi J; Gu W; Kanematsu T
    Liver Transpl; 2004 Jun; 10(6):734-42. PubMed ID: 15162467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel immunosuppressive proteins induced in rats by liver retransplantation.
    Kamada N; Goto S; Lord R; Kobayashi E; Kim YI
    Transplant Proc; 1995 Feb; 27(1):402-3. PubMed ID: 7879038
    [No Abstract]   [Full Text] [Related]  

  • 24. The presence of donor-reactive CD4 T cells in early-phase liver-induced tolerance in rats: analysis using donor passenger leukocytes from the recipient.
    Hashimoto T; Yamaguchi J; Gu W; Kanematsu T
    Transpl Immunol; 2006 Jan; 15(3):205-9. PubMed ID: 16431287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early immunosuppression withdrawal after living donor liver transplantation and donor stem cell infusion.
    Donckier V; Troisi R; Le Moine A; Toungouz M; Ricciardi S; Colle I; Van Vlierberghe H; Craciun L; Libin M; Praet M; Noens L; Stordeur P; Andrien M; Lambermont M; Gelin M; Bourgeois N; Adler M; de Hemptinne B; Goldman M
    Liver Transpl; 2006 Oct; 12(10):1523-8. PubMed ID: 17004249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New strategies in immunosuppression.
    Regazzi MB; Alessiani M; Rinaldi M
    Transplant Proc; 2005; 37(6):2675-8. PubMed ID: 16182781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion.
    Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP
    Transplant Proc; 1996 Dec; 28(6):3269. PubMed ID: 8962269
    [No Abstract]   [Full Text] [Related]  

  • 28. Induction of tolerance in a rat model of laryngeal transplantation.
    Akst LM; Siemionow M; Dan O; Izycki D; Strome M
    Transplantation; 2003 Dec; 76(12):1763-70. PubMed ID: 14688529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Selective immunosuppression with monoclonal antibodies against ICAM-1 and LFA-1 with FK 506 after experimental small intestine transplantation in the rat].
    Gasser M; Otto C; Timmermann W; Gassel HJ; Ulrichs K; Thiede A
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):595-9. PubMed ID: 14518324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of Foxp3+ regulatory T cells in liver transplant tolerance.
    Li W; Carper K; Zheng XX; Kuhr CS; Reyes JD; Liang Y; Perkins DL; Thomson AW; Perkins JD
    Transplant Proc; 2006 Dec; 38(10):3205-6. PubMed ID: 17175223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-2 receptor antibody versus antithymocyte globulin as part of quadruple induction therapy after orthotopic liver transplantation: a randomized study.
    Langrehr JM; Guckelberger O; Nüssler N; Radtke A; Lemmens HP; Jonas S; Lohmann R; Tullius S; Steinmüller T; Raakow R; Neumann U; Knoop M; Bechstein WO; Neuhaus P
    Transplant Proc; 1996 Dec; 28(6):3204. PubMed ID: 8962241
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunosuppressive 40-kd protein induced by orthotopic liver transplantation in rats.
    Lord R; Kamada N; Kobayashi E; Goto S; Sunagawa M
    Transplant Proc; 1995 Feb; 27(1):399-401. PubMed ID: 7879037
    [No Abstract]   [Full Text] [Related]  

  • 33. Tolerogenic and immunosuppressive properties of liver grafts in animals and man.
    Davies HF; Pollard SG; Calne RY
    Transplant Proc; 1991 Aug; 23(4):2248-9. PubMed ID: 1871862
    [No Abstract]   [Full Text] [Related]  

  • 34. Advances in immunosuppression therapy after liver transplantation.
    Norris S; Hegarty J
    Ir Med J; 1996; 89(5):168, 170. PubMed ID: 8936836
    [No Abstract]   [Full Text] [Related]  

  • 35. Costs of immunosuppressive therapies used in renal transplantation.
    Barclay PG; Allen RD; Stewart JH; Ng K; Chapman JR
    Transplant Proc; 1992 Feb; 24(1):165-6. PubMed ID: 1539225
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunosuppressive activity of serum from liver-retransplanted rats.
    Goto S; Kamada N; Lord R; Kobayashi E; Stamatiou S; Enosawa S; Toyama N; Ware F; Moore TD; Kim YI
    Transplant Proc; 1994 Aug; 26(4):2245. PubMed ID: 8066737
    [No Abstract]   [Full Text] [Related]  

  • 37. Specific immunosuppression and graft survival.
    Brent L; Hutchinson IV
    Transplant Proc; 1981 Mar; 13(1 Pt 1):541-6. PubMed ID: 6455800
    [No Abstract]   [Full Text] [Related]  

  • 38. Continued presence of donor leukocytes in recipients of liver grafts.
    Sriwatanawongsa V; Davies HS; Brons IG; Aspinall R; Thiru S; Jamieson NV; Calne RY
    Transplant Proc; 1993 Feb; 25(1 Pt 1):371-2. PubMed ID: 8438340
    [No Abstract]   [Full Text] [Related]  

  • 39. Potential GVHD inhibitory factors in the serum of liver re-transplanted rats.
    Edwards-Smith C; Goto S; Shimizu Y; Enoki T; Lord R; Vari F; Chiba S; Schlect D; Buckley M; Kamada N
    Transplant Proc; 1997; 29(1-2):853-5. PubMed ID: 9123553
    [No Abstract]   [Full Text] [Related]  

  • 40. Novel immunosuppressive proteins purified from the serum of liver-retransplanted rats.
    Goto S; Lord R; Kobayashi E; Vari F; Edwards-Smith C; Kamada N
    Transplantation; 1996 Apr; 61(8):1147-51. PubMed ID: 8610408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.